HIMS vs NBIX
Hims & Hers Health vs Neurocrine Biosciences — AI-powered side-by-side comparison
| Metric | HIMS | NBIX |
|---|---|---|
| AI Score | 40 | 63 |
| Price | — | — |
| P/E Ratio | -656.80× | 25.47× |
| ROE | 0.2% | 0.1% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.7% | 1.0% |
| Debt / Equity | 2.54× | 0.12× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 40.3 | 45.1 |
| Beta | 2.342 | 0.386 |
| Expected Upside | — | — |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
HIMS Full Analysis
NBIX Full Analysis